Literature DB >> 11529848

Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia.

E P Das-Gupta1, C H Seedhouse, N H Russell.   

Abstract

Using a sensitive fluorescent-polymerase chain reaction technique we looked for microsatellite instability (MSI) as functional evidence of mismatch repair defects in 71 cases of acute myeloblastic leukaemia (AML). MSI was assessed at 11 loci in matched leukaemic and constitutional DNA. Nine out of 71 patients (13%) were found to have MSI. Four of these patients had therapy-related leukaemia and the remaining five were all over the age of 60 years. There was a high incidence of adverse-risk cytogenetics in the patients with MSI, including abnormalities of chromosomes 5 and/or 7. Of the nine cases of t-AML included in this study, four (44%) had MSI. MSI was also seen in five of 51 cases (10%) over the age of 60 years but not in any cases under the age of 60 years with de novo AML. Using a sensitive assay, our results suggest that MSI occurs in two subgroups of patients with AML: those with t-AML and the elderly (> 60 years), but is rare in younger patients.

Entities:  

Mesh:

Year:  2001        PMID: 11529848     DOI: 10.1046/j.1365-2141.2001.02920.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

Review 2.  Genomic instability is a principle pathologic feature of FLT3 ITD kinase activity in acute myeloid leukemia leading to clonal evolution and disease progression.

Authors:  Melanie T Rebechi; Keith W Pratz
Journal:  Leuk Lymphoma       Date:  2017-02-06

Review 3.  DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.

Authors:  Maria Teresa Esposito; Chi Wai Eric So
Journal:  Chromosoma       Date:  2014-08-12       Impact factor: 4.316

4.  Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.

Authors:  Terzah M Horton; Patrick A Thompson; Stacey L Berg; Peter C Adamson; Ashish M Ingle; M Eileen Dolan; Shannon M Delaney; Madhuri Hedge; Heidi L Weiss; Meng-Fen Wu; Susan M Blaney
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

5.  Molecular characterisation of murine acute myeloid leukaemia induced by 56Fe ion and 137Cs gamma ray irradiation.

Authors:  Leta S Steffen; Jeffery W Bacher; Yuanlin Peng; Phuong N Le; Liang-Hao Ding; Paula C Genik; F Andrew Ray; Joel S Bedford; Christina M Fallgren; Susan M Bailey; Robert L Ullrich; Michael M Weil; Michael D Story
Journal:  Mutagenesis       Date:  2012-09-17       Impact factor: 3.000

6.  Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.

Authors:  Terzah M Horton; Gaye Jenkins; Debananda Pati; Linna Zhang; M Eileen Dolan; Albert Ribes-Zamora; Alison A Bertuch; Susan M Blaney; Shannon L Delaney; Madhuri Hegde; Stacey L Berg
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

7.  Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients.

Authors:  Fernando L A Fonseca; Aleksandra V L Sant Ana; Israel Bendit; Vitor Arias; Luciano J Costa; Aparecida A Pinhal; Auro del Giglio
Journal:  Breast Cancer Res       Date:  2004-11-04       Impact factor: 6.466

8.  No evidence for microsatellite instability in acute myeloid leukemia.

Authors:  C J Walker; A-K Eisfeld; L K Genutis; M Bainazar; J Kohlschmidt; K Mrózek; A J Carroll; J E Kolitz; B L Powell; E S Wang; R M Stone; R Bundschuh; A de la Chapelle; C D Bloomfield
Journal:  Leukemia       Date:  2017-03-24       Impact factor: 11.528

Review 9.  DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

Authors:  Ida Casorelli; Cecilia Bossa; Margherita Bignami
Journal:  Int J Environ Res Public Health       Date:  2012-07-27       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.